UB Paderborn / Katalog / Suche / in CDI

1 – 12 von 12

Sortiert nach

A 5-Year Open-Label Follow-up of a Randomized Double-Blind Placebo-Controlled Trial of Intralymphatic Immunotherapy for Birch and Grass Allergy Reveals Long-term Beneficial Effects

Journal of investigational allergology & clinical immunology, 2023-01, Vol.33 (5), p.362-372

2023

Volltextzugriff (PDF)

High‐dose pollen intralymphatic immunotherapy: Two RDBPC trials question the benefit of dose increase

Allergy (Copenhagen), 2022-03, Vol.77 (3), p.883-896

2022

Volltextzugriff (PDF)

Limited beneficial effects of systemic steroids when added to standard of care treatment of seasonal allergic rhinitis

Scientific reports, 2023-11, Vol.13 (1), p.19649-19649, Article 19649

2023

Volltextzugriff (PDF)

Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass: A randomized, double-blind, placebo-controlled trial

Journal of allergy and clinical immunology, 2018-10, Vol.142 (4), p.1338-1341.e9

2018

Volltextzugriff (PDF)

Intralymphatic immunotherapy in pollen-allergic young adults with rhinoconjunctivitis and mild asthma: A randomized trial

Journal of allergy and clinical immunology, 2020-03, Vol.145 (3), p.1005-1007.e7

2020

Volltextzugriff (PDF)

A five-year open follow up of a randomized, double-blind placebo-controlled trial of intralymphatic immunotherapy for birch and grass reveals remaining beneficial effects

Journal of investigational allergology & clinical immunology, 2022-06, p.0

2022

Volltextzugriff (PDF)

A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy

Allergy, asthma, and clinical immunology, 2020-04, Vol.16 (1), p.31-31, Article 31

2020

Volltextzugriff (PDF)

Novel strategies for the treatment of grass pollen-induced allergic rhinitis

Expert opinion on biological therapy, 2016-09, Vol.16 (9), p.1143-1150

2016

Volltextzugriff (PDF)

Autoimmune Pancreatitis Type 1 with Biliary, Nasal, Testicular, and Pulmonary Involvement: A Case Report and a Systematic Review

Journal of clinical medicine, 2023-10, Vol.12 (19), p.6340

2023

Volltextzugriff (PDF)

ILIT.NU - documentation of efficacy and dose finding for intralymphatic allergen immunotherapy in a phase II/III randomized, parallel group, double blind placebo-controlled multisite field trial

ALLERGY, 2021, Vol.76, p.27

2021

Volltextzugriff (PDF)

Intralymphatic immunotherapy (ilit) with both grass and birch allergen- a randomized double-blind placebo controlled trial

ALLERGY, 2017, Vol.72, p.120

2017

Volltextzugriff (PDF)

Survival of the Cortical Bone Columella in Ear Surgery

Acta oto-laryngologica, 1987, Vol.104 (1-2), p.158-165

1987

Volltextzugriff (PDF)

1 – 12 von 12

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(10)
Tagungsberichte
(2)

Sprache

Englisch
(12)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A 5-Year Open-Label Follow-up of a Randomized Double-Blind Placebo-Controlled Trial of Intralymphatic Immunotherapy for Birch and Grass Allergy Reveals Long-term Beneficial Effects

High‐dose pollen intralymphatic immunotherapy: Two RDBPC trials question the benefit of dose increase

Limited beneficial effects of systemic steroids when added to standard of care treatment of seasonal allergic rhinitis

Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass: A randomized, double-blind, placebo-controlled trial

Intralymphatic immunotherapy in pollen-allergic young adults with rhinoconjunctivitis and mild asthma: A randomized trial

A five-year open follow up of a randomized, double-blind placebo-controlled trial of intralymphatic immunotherapy for birch and grass reveals remaining beneficial effects

A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy

Novel strategies for the treatment of grass pollen-induced allergic rhinitis

Autoimmune Pancreatitis Type 1 with Biliary, Nasal, Testicular, and Pulmonary Involvement: A Case Report and a Systematic Review

ILIT.NU - documentation of efficacy and dose finding for intralymphatic allergen immunotherapy in a phase II/III randomized, parallel group, double blind placebo-controlled multisite field trial

Intralymphatic immunotherapy (ilit) with both grass and birch allergen- a randomized double-blind placebo controlled trial

Survival of the Cortical Bone Columella in Ear Surgery

Suchergebnisse filtern